View all veterinary jobs
VetSurgeon.org publishes a curated feed of veterinary news for practising veterinary surgeons, with a primary focus on the UK profession.
We select stories based on their practical relevance, clinical interest, or professional significance — filtering out noise so busy vets can stay informed quickly.
Our coverage includes:
We report across all areas of practice, including companion animal, farm, equine and exotic species.
Our editorial approach is deliberately selective and concise. We prioritise clarity and relevance over volume, aiming to make each story worth your time.
You can follow VetSurgeon News by subscribing to the daily, weekly or monthly email digest, or via our channels on Facebook and LinkedIn.
The Veterinary Development Council (VDC) is conducting a survey to investigate the role of paraprofessionals and technicians in veterinary practice, and is asking vets in large animal, equine, and mixed practices to complete a short survey.
The VDC says that information from the survey will help inform discussions on the regulation of technicians.
The survey will take between 5 and 10 minutes to complete and can be found on the BVA website at www.bva.co.uk/vdc. The BVA has also emailed the survey directly to practices.
The survey has been devised by the VDC working group looking at the role of the veterinary-led team, chaired by BVA Past President Professor Bill Reilly. This is one of three working groups that will report to the VDC:
Professor Reilly said: "The relationship between veterinary surgeons and technicians is vital but it varies from practice to practice.
"The working group on the role of the veterinary-led team aims to take a snapshot of how services, such as artificial insemination and foot trimming, are currently delivered, and gauge how veterinary surgeons feel about other services being delivered by non-veterinarians in the future.
"I hope veterinary surgeons in large, mixed and equine practice will take 10 minutes to complete our survey to help us map the current use of technicians in veterinary practice and help shape our future discussions."
'Period prevalence and mortality rates associated with hypocholesterolaemia in dogs and cats: 1,375 cases1' determined the period prevalence of hypocholesterolaemia and the associated mortality rates in dogs and cats at the Veterinary Medical Teaching Hospital, University of California, Davis.
The medical records of cats and dogs presenting to the hospital from 1st September 2011 to 30th August 2016 were retrospectively reviewed to identify all animals that had at least 1 cholesterol measurement; a total of 16,977 dogs and 3,788 cats were identified. Patient signalment and clinical information were collated from the medical records, including the primary disease processes in patients with moderate to severe hypocholesterolaemia. The period prevalence and mortality rate of hypocholesterolaemia were calculated.
The period prevalence of hypocholesterolaemia was 7.0% in dogs and 4.7% in cats. The mortality rate of hypocholesteraemic dogs and cats was 12% in both species, which was significantly higher than that of animals with normal serum cholesterol.
Steven Epstein, corresponding author for the paper, said: 'The odds of death in dogs and cats with hypocholesterolaemia were 3.2 and 2.5 times higher than in those with normocholesterolaemia respectively. Furthermore, there was a significant linear trend towards higher mortality in association with more severe hypocholesterolaemia in both species.
'Disease of the hepatic, gastrointestinal and lymphoreticular systems were most commonly associated with hypocholesterolaemia, and infectious and neoplastic disease were the most commonly associated pathophysiological processes in both species. In dogs with neoplasia, lymphoma was over-represented.'
Nicola Di Girolamo, Editor of JSAP said: 'These findings suggest that low cholesterol levels are associated with mortality in canine and feline patients. It is not clear whether hypocholesterolaemia is simply a marker for disease severity, or if it has active physiological effects contributing to poor outcomes. At this stage, it seems indicated to enhance intensity of diagnostic effort and therapy for affected animals.'
The full article can be found in the November issue of the Journal of Small Animal Practice which is free for BSAVA members. It can also be read online here: https://www.onlinelibrary.wiley.com/doi/10.1111/jsap.13204
Reference
A donation of 200 Tracer microchips by Bayer is helping to save one of the world's largest and rarest species of frog against extinction. A deadly fungal disease, responsible for decimating global amphibian populations, is threatening the last known wild population of the 'mountain chicken' frog (Leptodactylus fallax).
The eastern Caribbean island of Montserrat is the last global stronghold for this species - known locally as mountain chicken due to its taste. As recently as 2002, chytridomycosis wiped out the majority of mountain chicken frogs on the island of Dominica. Recent tests on dead frogs found in the west of Montserrat have confirmed the presence of this disease.
The Durrell Wildlife Conservation Trust has been working in Montserrat since the early 1990s to support the local government in the protection of the island's vast biodiversity. The mountain chicken has been an important species, and Durrell holds the largest safety net population at its Jersey headquarters.
In response to the positive identification of the disease, Durrell has launched an emergency plan to rescue healthy frogs and put in place longer treatment and management plans for the protection of the species.
Bayer's donation of 200 Tracer microchips will be used to individually identify the captive mountain chickens held by Durrell to help manage a breeding programme. Durrell is also testing the feasibility of treating the frogs with antifungals in their natural habitat, and the use of the donation of microchips will be essential to allow individual frogs to be monitored to assess the outcomes of treatment regimes.
Durrell's head of veterinary services, Javier López, has worked with mountain chickens for a number of years, and explains that the disease could very quickly wipe out the species. Captive populations of healthy frogs, such as the one in Jersey, could be used to initiate re-introductions back to the wild or in disease-free areas.
Idexx Laboratories has launched a new renal function test, Idexx SDMA, which the company says can detect chronic kidney disease (CKD) in dogs or cats months or even years earlier than traditional methods.
The test is based on a new renal biomarker - symmetric dimethylarginine (SDMA) - and is the result of collaboration with a number of global experts.
Simon Wootton, UK CAG Marketing Manager at Idexx said: "The high sensitivity of this marker for detecting CKD will allow vets to diagnose the disease a lot sooner than has been previously possible. Identifying the disease earlier will give vets more time to intervene and prescribe an appropriate course of action."
The company says that the Idexx SDMA test can identify renal disease in dogs up to nine months earlier than previous methods, while in cats the detection time can be up to 17 months earlier.
Dr Martha Cannon, BA VetMB DSAM(fel) RCVS Recognised Specialist in Feline Medicine of the Oxford Cat Clinic, said: "The launch of SDMA testing is very exciting. It offers the prospect of identifying chronic kidney disease at an earlier stage, which should mean we can treat it more effectively and allow us to maintain cats in the asymptomatic phase. This can improve longevity, but more importantly could help maintain a better quality of life for longer.
"SDMA is also unaffected by muscle loss, which will allow us to assess the true extent of CKD in our elderly and underweight cats. This will lead to improved treatment choices, better quality of life and more peace of mind for owners."
The value of the new test has been validated by the adoption of SDMA into the International Renal Interest Society (IRIS) guidelines as a biomarker for the early detection of CKD.
Jonathan W. Ayers, President and Chief Executive Officer of Idexx Laboratories, said: "Idexx SDMA is a result of our commitment to lead the industry in sustained research investments that serve to advance veterinary medicine. It represents a significant achievement in veterinary diagnostics. Hospitals in the USA already using Idexx SDMA have told us that it has transformed the way renal disease is diagnosed and treated."
Idexx SDMA is available to UK and Ireland reference laboratory customers now. Further information is available at www.idexxsdma.com.
Video shows Sylvia Conway MRCVS, UK Medical Affairs Consultant at Idexx, talking about the new test (can also be viewed here).
Sophia Salmon MRCVS from Central CPD said: "All of the major corporate chains in the UK now deliver a significant proportion of their clinical and non-clinical staff training via online learning platforms. These systems form an important part of professional development, training standardisation and even performance evaluation.
"However, learning platforms can be expensive to procure and develop, as well as being time-consuming to maintain, and therefore may not be viable for smaller businesses."
Central CPD has used its experience providing online learning to several of the UK’s major corporate veterinary groups to create 'Central CPD On-Demand', which features over 1500 clinical and non-clinical CPD videos for vets, nurses, managers and receptionists.
There's a new practice subscription package which, developed with whole-team learning in mind, costs £2000 per year for up to twenty people (veterinary surgeons, nurses or management staff).
Central CPD says the new package allows individuals and practices to set their own learning plan for the year, and for mentors to build and supervise training programmes for other staff members.
Practices can add their own content, such as policy documents, in order to assist with the delivery of compulsory elements of staff training.
Central CPD says its service is a fraction of the cost of procuring and populating an off-the-shelf learning platform, and the company is staffed by vets and vet nurses who are available to provide one-to-one advice and support to help practices set up their team’s platform and get the most out of the system.
For more information, visit: https://centralcpd.co.uk/
The programme includes more than 130 hours of CPD delivered by over 100 speakers from home and abroad, with talks for all members of the practice team.
The UK speakers include Rebecca Geddes on kidney medicine and nursing; Amy Newfield on IV access techniques; Rob White on brachycephalic surgery and acute abdomen surgical techniques; Penny Watson on liver disease; Dick White on the surgical team; Butty Villiers on cytology for vets and nurses; John Chitty on several rabbits, small furries and exotics topics.
BSAVA President, Professor Ian Ramsey, said: “Following months of meticulous planning we are thrilled that the programme is now live
"The sheer range and high quality of our speakers and content, together with our new, more dynamic format takes webinar learning to a new level."
“Delegates will be able to develop their skills and knowledge on topics they see regularly in practice. To make things even easier we will be providing practical resources such as client handouts for delegates to take back to their clinics. This, coupled with many speakers sharing their own notes and practical resources means less note-taking and a quicker and easier way for delegates to share what they have learnt with their colleagues.”
There will be three keynote speakers; Jenny Campbell, a former Dragon on BBC’s Dragon’s Den, will be sharing her experiences as an entrepreneur and business leader. Two other keynote names will be announced shortly.
On the social side the focus is on bringing people together online to share light-hearted entertainment and laughter. Delegates can exercise their taste buds with some wine and whisky appreciation, throw some shapes with a virtual disco, exercise their bodies as well as their minds with yoga and unwind with some restorative meditation practices.
Ian added: “This year’s BSAVA Congress is going to be the most innovative ever and deliver like never before. There is plenty of relevant and engaging CPD for every practice professional, with all the convenience of a virtual event. If you haven’t already taken a look at the programme and registered, I urge you to do so now. With prices starting at just £99 +VAT for members it represents really great value.”
To register now visit https://www.bsavaevents.com/bsavacongress2021/en/page/home
Humanimal Trust is the only organisation in the UK with the sole purpose of progressing One Medicine, driving collaboration between vets, doctors, nurses and researchers so advances in both human and animal medicine can be achieved faster.
The seminar, entitled One Medicine in Action – Awareness, Collaboration and Change, follows on from the Trust’s inaugural symposium last year when a roadmap was created on how to develop closer links between human and veterinary medical and research professionals.
This year’s event will look at ways to put the roadmap into action through awareness raising, increased collaboration and change.
Professor Roberto La Ragione, Chair of Trustees at Humanimal Trust (pictured right), said “We know that when animal and human health professionals and scientists come together, great things happen.
"Last year’s symposium, which was part of our ‘Stronger Together’ campaign, was a huge success.
"It drew an audience from across the UK and Europe, as well as Chile, the United States, Singapore and Australia.
“Not only did it provide a real opportunity to explore ways to achieve more ethical and fair medical progress for all, but it also allowed connections to be made and relationships to be forged that wouldn’t otherwise exist.”
Miss Anna Radford, a Consultant in Paediatric Surgery at Hull University NHS Trust and Leeds Children’s Hospital, who is speaking at the seminar in May, said: “I was introduced to a diagnostics company working in the animal medical care field at last year’s symposium and through them, we have set up a new collaboration with the aim of determining whether this sort of diagnostic technology developed with companion animal medicine in mind, could potentially also be useful to help diagnose urinary, joint and cerebrospinal fluid infections in a busy NHS hospital setting.”
Other speakers at this year’s event include Dr Deborah Thomson, Founder and President of One Health Lessons, an organisation that inspires children and adults around the world to value the interconnection between human health and the health of the environment, plants and animals.
Dr Simon Doherty, a Senior Lecturer at the Institute of Global Food Security at Queen’s University in Belfast will highlight organisations that are successfully working together to improve the sustainability of dairy, meat and fish production to feed a growing global population, as well as the opportunities that exist for collaboration within the agri-food sector.
Dr Doug Brown, CEO of the British Society for Immunology, will share some of the most notable examples of joined-up approaches in human and animal health research from across the Society’s membership, with a particular focus on veterinary immunology.
The seminar, which will run from 2pm until 5.15pm BST, will end with a panel Q&A session, chaired by Humanimal Trust Trustee and Consultant Respiratory Physician at the University Hospital Southampton NHS Foundation Trust, Dr Ben Marshall.
Attendance is free and registration is now open to all human and veterinary medical professionals and students, and the allied health and scientific disciplines.
To find out more and register, visit www.humanimaltrust.org.uk
BSAVA’s client information leaflets are designed to be used as part of the veterinary consultation and provide information to help owners understand what is involved in a procedure or examination, including the reasons for it, the preparation required, any associated risks and what happens during and after the procedure.
They are available in a PDF format which can be printed and stamped with the veterinary practice details or emailed to clients.
Elise Robertson, ABVS American Board-Certified Diplomate Feline Practice and author of the endoscopic Client Information Leaflets, said: ‘The client information leaflets were created due to the need for accurate and reliable information from reputable sources."
BSAVA’s Head of Publishing, Ian Mellor, said: "This new factsheet brings our total number of client leaflets to 178. Our client leaflets have been downloaded more than 10,000 times in the past year and are an important part of our drive to improve the health and welfare of small animals by providing practical resources to the veterinary profession.’
The new leaflet is available via the BSAVA Library (https://www.bsavalibrary.com/content/cilgroupprocedures).
Access to the entire range of client information leaflets (including canine and feline behaviour, exotic pets and medicines) is available for an annual subscription of £40; BSAVA members have access to these leaflets as one of their membership benefits.
BSAVA welcomes suggestions for new topics to cover in its client information leaflets.
Send your ideas to publications@bsava.com.
The RCVS Disciplinary Committee has reprimanded a veterinary surgeon for submitting a certificate of Clinical Inspection for Veterinary Inspectors ("TB52") for tuberculin tests he had undertaken on cattle, despite knowing that he had not fully complied with the standard operating procedures (SOP) for these tests.
At the outset of the three-day hearing, John Wilson admitted that, when acting as an Official Veterinarian (OV) he had not carried out tuberculin tests on cattle at a Wiltshire farm on 19 May 2011 strictly in accordance with the SOP required by the Animal Health and Veterinary Laboratories Agency (AHVLA), an executive agency of Defra.
The admitted shortcomings were that on 19 May, the second day of testing, Mr Wilson had failed to confirm the identity of all the animals, failed to inspect the animals digitally (ie using his hands) and had not measured the fold of skin at the injection site of all the animals. The College argued that this was contrary to the directions of the AHVLA and, in subsequently signing the TB52 certificate, he was either dishonest or should have known that the certification was incorrect. Mr Wilson admitted that he ought to have known the certification was incorrect but denied dishonesty, because he believed that he had conducted the test in a satisfactory manner and had correctly identified all the reactors in the herd.
Mr Wilson was a veterinary surgeon of over 40 years experience and unblemished record, and the Committee found his account of events to be accurate and honest. He said the farm involved was unprepared and test arrangements were chaotic, with poor handling facilities, and he would have been concerned for the safety of the animals and their handlers if he had complied fully with the SOP. He had advised the farmer to delay the test but his advice was rejected.
The Committee accepted that the testing had been carried out under exceptional and difficult circumstances. It noted that Mr Wilson had identified a reactor and taken appropriate actions, knowing that the outcome would be the quarantining of the whole herd. He had made no financial or other gain, other than the nominal fee charged for the work. Although failing to comply with the SOP fell short of what was expected of a veterinary surgeon, because of these circumstances, and as he had acted in what he considered to be the best interests of the animals and personnel, these actions did not amount to serious professional misconduct.
The Committee found that, even allowing for these difficulties and concerns, in signing the TB52 certificate a few days later, without any qualification, Mr Wilson ought to have known that it was incorrect, and his actions fell far short of the standards expected of the veterinary profession. They did not however find that he had been dishonest.
The Committee stressed the importance attached to accurate and reliable certification, in maintaining the confidence of the public and the profession, and in ensuring animal welfare.
Professor Lees, chairing and speaking on behalf of the committee said: "The Committee is aware, as confirmed by AHVLA, that this is a single, isolated event and the first offence in some 40 years of the Respondent working as a LVI [local veterinary inspector] or OV. After considering all the mitigating factors.and, given the exceptional circumstances of this specific case, the decision of the Committee is to reprimand Mr Wilson."
Zoetis has launched PetDialog and HorseDialog, the only treatment reminder apps for pet and horse owners which veterinary practices can customise with their own branding.
The app is downloadable from the Apple and Android app stores, but is only accessible by inputting a unique practice identity code.
Once the app is unlocked, owners can then input details of any medications their pet is taking and the date its healthcheck / vaccinations are due, after which they'll receive a practice-branded email reminder.
It's a similar idea to Bayer's reminder app released earlier this year, but with the very clever addition of practice branding.
John Toole, Product Manager at Zoetis said: "This is absolutely the right time to launch this app. Smartphone ownership has rapidly increased from 38% to 60% in the last three years and by 2015 it is predicted that 73% of the UK population will own a Smartphone. The use of Smartphones is no longer just the domain of the young - use and ownership is pretty evenly spread among age groups between 24 and 64, with greatest growth among the 44 -74 age group over the past three years. It comes as no surprise that recent market research confirms 57% of UK pet owners own an Android or iOS device.
"Health businesses are the most trusted by UK mobile users when it comes to receiving mobile messages. More than 11 million consumers have opted in to receive mobile messages from health companies, particularly to take advantage of appointment reminders. This form of communication can really boost loyalty where vet practices are concerned, as 74% of users say that mobile messages that had a use or benefit would maintain or enhance their loyalty to that brand.
"PetDialog has been a significant investment for us and with the help of our customers we plan to re-invest in a robust development stream to ensure the app becomes a valuable tool for pet owners and practices alike. To help practices launch and market the app we've developed an extensive bespoke range of marketing support materials from web pages and email templates to practice posters that come alive in the waiting room with augmented reality."
VetSurgeon gave the app a very quick trial. We found registration simple and easy. Clear navigation. Very good first impression.
Except ...
Honestly, whose idea was it that even the most pathologically insane pet owner would possibly, even once in a million years, want to record (and chart) the amount of time they spend hugging their pet. And not just that, but also to categorise their pet-hugging activities according to whether it was 'Morning Cuddles', 'Afternoon Hugs' or 'Evening Snuggles'. Someone at Zoetis' digital agency must have been smoking something very strong when they came up with that one.
Similarly, the ability to record the amount of time spent playing with the dog, breaking it down into specific activities such as: 'Fetch', Tug of War', 'General Playing', is surely targeted at the 0.0000000001% of the pet owning population that really should be getting some sort of professional help.
That said, the overall idea and execution is top notch. Provided Zoetis removes the madder elements of the app at the next upgrade, it'll get 5 stars out of 5. Meantime, it's still highly recommended.
For more information about the app, contact your Zoetis Account Manager
Forum Animal Health, makers of Apometic, an emetic for dogs, has launched a campaign to raise awareness among vets about the dangers of human foods to dogs, particularly over the festive period.
According to the PDSA, almost half a million dog owners are still giving them chocolate treats intended for human consumption1 despite the fact that 85%2 of consumers know chocolate is poisonous to dogs,.
Chocolate is, of course, not the only human food that is dangerous to dogs. Other treats such as mince pies and Christmas cake (containing raisins or sultanas), as well as food containing onions and leeks, plus sweeteners and human medication, are all potentially lethal if not treated as soon as possible.
The company is also stressing the importance of dog owners presenting their pets at the vets as soon as possible after eating something potentially harmful. Tim Gooders, UK Companion Animal Product Manager at Forum Animal Health said: "During the festive season clients often don't recognise what is poisonous and don't know what to do if there is a problem. Their instinctive response is to wait and see, however, animals need to be treated quickly before they have metabolised what they have eaten." He added that Apometic is most effective if the animal is presented early, pre poisoning.
In order to help raise awareness and alert owners about the importance of acting promptly, the company has created a range of posters which can also be downloaded and printed out from its website.
References
Forum Animal Health data on file
PDSA PAW report 2013 press release April 2014
Virbac has launched the BackHome Mini Chip, a microchip which is 8mm long compared to the existing standard which is 12mm.
The new Mini Chips are made of a pharmaceutical grade glass with an anti-migration coating. Because of their smaller size, they can be implanted with a needle that is 34% smaller than the standard needle. Virbac says this can minimise stress and discomfort during implantation.
Virbac has also announced a partnership with VetEnvoy, a service which works with practice management software to enable pet and owner registration details for BackHome Mini Chips to be uploaded to the Petlog database at the press of a button, saving support staff time completing online or paper application forms and reducing the number of errors.
Sarah Walker MRCVS, Product Manager, said: "Microchipping is the most effective way for owners to protect their pets and will soon become compulsory for dogs in England and Wales. Some owners are deterred from undertaking this important and simple procedure because they are concerned that it may be painful. Because our new BackHome Mini Chips are smaller and are implanted with a smaller needle, we hope that practices will be able to reassure their clients that microchipping will not cause their pet discomfort - and that the protection it offers will last a lifetime.
“Our relationship with VetEnvoy will also spare enabled practices some of the administration time spent processing microchip details, and reduce the number of mistakes in registration and any resulting complaints.
"Client information on BackHome Mini Chips is stored on Petlog, the UK's largest pet database, giving owners the best possible chance of being reunited with their pet, as long as they keep their registration details up to date."
Although microchipping has been a legal requirement for dogs since April 2016, it is not currently required for cats unless they are travelling under the Pet Travel Scheme.
Cats Protection says microchipping should become a legal requirement for owned cats and is petitioning for change in the law. At the moment, it says, eight out of ten stray cats taken in by its adoption centres in England are not microchipped, making it virtually impossible to trace the owner.
Cats Protection’s Chief Executive, James Yeates, said: "Introducing compulsory microchipping of owned cats would encourage more cat owners to microchip their cats, meaning that lost cats can be identified and returned home rather than handed into rehoming charities as strays.
"It also means that injured cats can be quickly identified by vets and their owners can be informed and involved in their care.
"We’re delighted the Government has shown a commitment towards improving feline welfare and promoting responsible cat ownership in the UK by announcing this call for evidence."
Environment Secretary, Theresa Villiers, said: "Today’s call for evidence on cat microchipping will help the government understand how we can better protect this country’s much-loved cats and kittens. This government is committed to animal welfare and improving the lives of our companion animals."
The call for evidence will last for 12 weeks and respondents are being encouraged to respond as soon as possible. You can take part here.
PBD Biotech says the Actiphage test offers the potential to revolutionise control of bovine TB by allowing detection of the disease within hours from a blood or milk sample.
Last November, the Welsh Government announced a new policy that allowed the use of non-validated tests such as Actiphage in herds affected by a TB breakdown. It followed a similar protocol to one authorised by the UK Government last year for cattle herds in England after the test was used as part of a successful private eradication plan on a Devon dairy farm.
Mossman Farming, in Ceredigion, is located in an area of chronic breakdown. It is a spring-calving milking herd with a total stock of 529, to date 312 dairy cows have been slaughtered. Farmer Chris Mossman agreed to trial Actiphage after hearing about the Gatcombe pilot.
Chris said: "TB is a massive problem in Ceredigion, so when I heard about Actiphage’s use at Gatacombe, helping to clear that dairy herd for the first time in six years, I wanted to try and replicate those findings here. Me – and many other farmers – are losing large numbers of animals. I’m trying to do all I can to get rid of this disease from my herd."
In Spring 2019, The Office of the Chief Veterinary Officer for Wales granted permission for Robert Price-Jones MRCVS to use Actiphage to screen high-risk cattle for M. bovis.
Robert, who has been leading the trial, said: "Actiphage is able to identify the presence of relatively low numbers of M. bovis in the blood stream of infected cattle. It is not dependent upon an immune system response to the pathogen - in contrast to current validated tests - and so has greater sensitivity than such as the official Tuberculin SICCT skin test.
"The benefit of using Actiphage is that it offers the potential for eradicating the disease from the farm; as early identification of animals at risk of bovine TB enables heightened disease management and control."
Under the terms of the Welsh Government’s protocol, cattle not condemned for slaughter can be tested with Actiphage. Those that give a positive result are identified with a ‘management’ marker, monitored and milked separately.
To prevent further contamination of the environment and to minimise risk to uninfected cattle, animals found to be ‘shedders’ are removed from the farm.
Although a decision to remove cattle based on a non-validated test will be at the farmers’ own expense, the APHA (Animal and Plant Health Agency) has confirmed that during the trial, where a positive result is confirmed with statutory tests, the animals will be removed with compensation as normal.
So far, 100 animals from Mossman Farming have been tested with Actiphage and Robert Price-Jones is preparing a paper to publish the findings in early 2020.
PBD Biotech is now seeking more farms to trial Actiphage in order to gain the World Organisation for Animal Health (OIE) validation. The company is offering reduced cost testing to support trials where the findings are made available to support validation of the test.
The practice's first residents are Sara Cermeno Fernandez and Lucy Venman (pictured right), who began their programmes last month after completing successful internships.
Cave’s clinical director Nele Van den Steen, an RCVS and European specialist in internal medicine, said: “We are naturally very pleased to have achieved this milestone and are delighted to get started, with our first residents Sara and Lucy continuing their career development with us.
“To be approved for a residency programme, you have to show you can support the caseload required and provide the training which the residents will need.
“So, this accreditation shows we have the integrity and the capacity to support the programme, which is a notable achievement and a ringing endorsement of our work here at Cave.”
For more information, visit cave-vet-specialists.co.uk.
The ‘2022 AAFP/ISFM Cat Friendly Veterinary Interaction Guidelines: Approach and Handling Techniques’ and the ‘2022 ISFM/AAFP Cat Friendly Veterinary Environment Guidelines’ cover all aspects of a cat’s veterinary experience, including the journey to the practice and interactions with veterinary team members, as well as the clinical environment.
The new guidelines cover things like:
Dr Nathalie Dowgray, Head of ISFM (pictured right), said: "We are extremely proud of our new guidelines; they have been a lot of hard work with large amounts of literature to review and multiple time zones to work across, but the effort has been worth it.
"We hope all veterinarians working with cats will take the time to read them and apply the concepts and ideas to their clinics and to how they personally interact with their feline patients.’
The guidelines are available at: https://journals.sagepub.com/page/jfm/collection/cat-friendly-special-issue
Complete Veterinary Care (CVC) is to launch the BooBooLoon, a new alternative to the Elizabethan collar at BSAVA Congress.
According to the company, the inflatable collar offers comfort and protection advantages over old style Elizabethan collars and other devices that restrict pets from harming surgical wounds and irritating skin disorders.
The BooBooLoon, which is made in the US by a manufacturer called Headroom, will be distributed by CVC to veterinary professionals and pet shops. The collar will be available in five sizes from extra small through to extra large.
Marcy Colangelo, President of Headroom invented the device when her boxer dog Mitzi had surgery for skin cancer. She said: "I just couldn't stand leaving that cone on her. It was like putting her head in a tunnel."
Inspired by her own travel pillow, she came up with the BooBooLoon.
Marcy added: "I know the entire CVC Group administrative and veterinarian management team are enthusiastic about their upcoming BooBooLoon inflatable pet recovery collar launch. The CVC Group is very experienced and is committed to providing excellent service and quality to the veterinary profession and to independent pet shops throughout the United Kingdom."
Boehringer Ingelheim Vetmedica has announced that it will be launching Bovela, a new viral diarrhoea (BVD) vaccine, to farmers during April 2015.
Allan Henderson from Boehringer said: "BVD remains the most common viral disease affecting cattle throughout Europe, despite vaccines being available for over 15 years. We asked farmers why this was the case and, without exception, they remarked that current vaccine protocols are unwieldy, requiring precise timings making them hard to follow.
"Bovela is a unique one-shot vaccine that can be used in cattle from three months of age and also whether pregnant or not. Other, currently available vaccines require a two-dose primary course with boosters annually or even every six months thereafter."
BVD is spread within herds and to new herds through the presence of persistently infected (PI) animals. PIs can look relatively healthy and show no outward signs of infection but, as they were exposed to the virus as a foetus, have become virus carriers. If they are born alive, they will shed virus consistently throughout their lives so perpetuating the cycle of infection.
Alan said: "The foetal control delivered by Bovela gives absolute confidence that cows will not produce PIs. This, alongside the drastically improved convenience will undoubtedly make Bovela the natural choice for many farmers, both on beef and dairy farms."
According to Boehringer, around 60% of cattle in the EU test positive for exposure to the BVD virus and, although BVD type 1 is currently the most common form, outbreaks of BVD type 2, were confirmed in 2013 and 2014 in Belgium, Germany and The Netherlands. BVD type 2 is generally a more serious disease, with high levels of mortality and while the virus has been identified in UK, it has not yet been identified as the cause of serious outbreaks of disease in cattle.
Alan said: "Bovela is the first and only vaccine in UK which has been proven to protect cattle from BVD type 1 and 2. It has been in development for 17 years and, gained a marketing authorisation following assessment of an unprecedented quantity of data generated in both beef and dairy herds.
"Work has looked at the efficacy of Bovela in preventing the production of PI calves and against type 1 and 2 BVD as well as confirming its efficacy in young calves as young as three months of age as their natural maternal protection wears off. Trials also confirmed vaccine safety generally and during various stages of pregnancy. We do not believe that any other BVD vaccine has been tested as rigorously."
The study, which examined cattle farmers’ and veterinary surgeons' opinions of pain-induced distress associated with disbudding, analgesia and attitudes and the use of non-steroidal anti-inflammatory drugs (NSAIDs), suggests that in particular, vets need to refine their understanding of farmers’ priorities, and how they guide clients on methods to improve calf welfare.
There have been a number of studies into the pain-induced distress resulting from the disbudding procedure. All methods of disbudding (apart from chemical cauterisation) in the UK require the use of a corneal nerve local anaesthetic blockade but there are currently no legislative requirements for the use of NSAIDs for disbudding – it is at the discretion of the farmer or veterinary surgeon carrying out the procedure. NSAIDs are routinely used in companion animals and equine practice, but less so in farm animals.
This new study, conducted by researchers at the Royal Veterinary College (RVC) in Hertfordshire and Aran Vet Clinic in Gwynedd, looked at the attitudes of farmers and vets on pain perception and pain management methods for disbudding. A total of 118 vets and 140 farmers contributed to the study. Of the respondents:
The study concluded that veterinary surgeons underestimate the influences of welfare and analgesic duration and effectiveness on farmers' decisions, and overrated cost impact. This perception could have a negative effect on veterinary recommendation.
The authors of the study therefore advise that steps should be taken to address the current inadequacies in the communications between vets and clients in conveying the practicalities and potential benefits of using NSAIDs.
Dr Troy Gibson, PhD, PGDipSci, BSc, Lecturer in Animal Welfare Science at the Royal Veterinary College said: "Despite the large amount of evidence of the benefits of NSAIDs for disbudding, it is disappointing that their use is still not widespread. This may partly be due to the only recent licencing of one NSAID for cattle. However, from our work it is clear that one of the key barriers to wider uptake is the breakdown in communication between veterinarians and their clients in conveying the cost, practicalities and potential benefits of NSAID use for disbudding. The wider use of NSAIDs in combination with local anaesthetics during disbudding would significantly improve calf welfare."
The review will consider whether the UK Veterinary Medicines Regulations 2013, which were were originally derived from EU legislation, protect animal and public health without adding unnecessary regulatory burden.
Anyone is able to share their views and experiences of the regulations, but the VMD is especially interested in hearing from vets, vet nurses, SQPs, marketing authorisation holders, farmers and pet owners.
Responses must be submitted before 23:59 on 26th September 2025
https://consult.defra.gov.uk/vmd-policy-development-and-delivery-office/mmd-act-2021-stakeholder-survey
Following a survey which indicates that veterinary surgeons are largely using unproven supplements to manage early-stage osteoarthritis, Hill's Pet Nutrition is calling upon vets to use evidence-based clinical nutrition to manage the condition.
The survey, which was carried out by independent market research firm Zyman Group, found that vets are more likely to give supplements than any other treatment in early stage osteoarthritis: 66% of cases receive supplements, 45% are given NSAIDs, and only 20% receive dietetic pet food.2
According to Hill's, its Prescription Diet j/d dry is clinically proven to improve mobility in osteoarthritic dogs in as little as 21 days; and 28 days in cats.3,4 Furthermore, the clinical study assigned to j/d is classified as Grade 1 level evidence - the highest grade reflecting the validity of clinical evidence. Another study has shown that Prescription Diet j/d also helps reduce NSAID dosage by up to 25 percent in dogs.5 This quality of evidence is, says Hill's, in contrast to many supplements.
John Innes, Professor of Small Animal Surgery at Liverpool, was involved in some of the early work on j/d: "Our results showed that the EPA in Hill's Prescription Diet j/d Canine pet food helped to reduce proteoglycan loss from cartilage. This would have beneficial effects in helping to preserve loss of cartilage. By preserving the cartilage, we can reduce pain in the long-term and ensure greater mobility for dogs with osteoarthritis."
Hill's has also announced that because a substantial majority of vets and nurses said that they felt that natural GACs have a positive effect in osteoarthritis1, its Prescription Diet j/d dry has been enriched with glucosamine and chondroitin sulphate.
Hill's j/d programme is now backed with money off vouchers, to improve client acceptance of veterinary recommendation. Clients who register on the website http://www.hillspetmobility.co.uk/,or http://www.hillspetmobility.ie/, will receive two £10 (or €10) money off e-coupons to use in clinic on their next purchases of j/d. They will also receive monthly e-mails containing information on how to take care of their pet with mobility problems, and help drive them back into the clinic for check-ups.
Veterinary surgeons who would like more information on the studies proving clinical efficacy, or score cards and trial guides for clients, should contact their Hill's Territory manager or call 0800 242438 or in ROI 1 800 626002. Clients can also fill in the scorecard online at www.hillspetmobility.co.uk or http://www.hillspetmobility.ie/
The original survey was sent last year to more than 5,000 UK-registered veterinary surgeons and veterinary nurses who gained their qualification from a non-UK EU institution, with a response rate of around 55%.
This year the Institute for Employment Studies (IES), on behalf of the RCVS, contacted over 6,000 veterinary surgeons and almost 50 veterinary nurses – including those previously surveyed as well as EU registrants who have joined since the last survey – who trained in non-UK EU countries to seek their views on the implications of Brexit for European veterinary professionals.
Chris Tufnell, RCVS Senior Vice-President and Chair of the College’s Brexit Taskforce, said: "The aim of this survey is to gain a greater understanding of the views and expectations of our EU colleagues now that certain elements of the UK’s withdrawal process from the European Union, as well as the timing, have become clearer. The survey will also be looking for the views of colleagues on how the College has addressed the challenges of Brexit so far.
"It is particularly important that those who responded to last year’s survey do so this year because the aim is to get a sense of how their views and plans are shifting as the Brexit process moves forward."
As with last year’s survey, the views collated through the consultation will help the College understand the immediate and longer-term impact of the UK’s exit from the EU, gather evidence that could be used to make a case for special treatment of veterinary professionals with regard to future immigration policies and allow the College to provide informed advice to European veterinary professionals as they make decisions about their future careers.
Dr Tufnell added: "I would strongly encourage EU veterinary professionals to respond to this survey, even if they didn’t do so last year, as their views really do matter to us and really do have an impact on our Brexit policies and the views we put forward to the government in these critical times."
The deadline for sending responses to the IES is Wednesday 18 July 2018 and all data will be managed and analysed by IES, an independent not-for-profit research institute, on a confidential basis with no individual responses being seen by the RCVS.
The College says it intends to conduct a third survey when the terms of the UK’s withdrawal from the EU, and the impact of this on non-UK EU nationals, are better defined.
The full eligibility criteria, including FAQs and guidance notes, for veterinary surgeons who wish to stand for RCVS Council can be found at: www.rcvs.org.uk/rcvscouncil21. The deadline for nominations is 5pm on Sunday 31 January 2021.
Due to the ongoing postal problems caused by the coronavirus pandemic, RCVS Council has approved a temporary change to the RCVS Election Scheme this year to allow nominations to be submitted electronically, rather than in hard copy. This temporary change is currently before the Privy Council for final approval.
Eleanor Ferguson, RCVS Registrar and Returning Officer for the elections, said: "For prospective RCVS and VN Councils election candidates this will mean that, rather than having to send us hard copies of your nomination documents in the post, these can simply be emailed to the College along with the relevant digital photographs and electronic signatures."
The College has also updated its information and guidance for prospective candidates, including an informal ‘job description’, to help them better understand what it means to be members of RCVS Council, their responsibilities, commitments and how they help the College meet its strategic goals, as well as the principles and rules governing their conduct.
Prospective candidates for RCVS Council can also contact RCVS President Dr Mandisa Greene for an informal conversation on what it means to be a Council member on president@rcvs.org.uk.
Mandisa said: “As I have often said publicly, when I decided to stand for RCVS Council it was out of a mixture of fear and curiosity, the RCVS seemed liked some distant organisation that was often talked about, but not entirely understood, and that made me want to find out more. It is fair to say that, since joining RCVS Council, I have learned and experienced a great deal, have got to know people in our profession that I would otherwise never have had the opportunity to meet, and have been at the forefront of key discussions about how our profession is regulated and its future.
"Throughout my time on Council I have also been a working mother of two young children and so, for those who are concerned about how being a Council member can fit around personal and professional life, I can assure you that there is flexibility that allows you to carry out your Council work around other commitments.
"I do hope that, if you are interested in the future of our professions and having a say in our professional and educational standards and how we are governed, then please take the time to consider becoming a member of RCVS Council and don’t hesitate to get in touch with me if you want to know anything more."
There is one more Council meeting before the nomination period ends. It will take place online on Thursday 21st January 2021 and prospective candidates who would like to get a feel for it are welcome to attend as observers: contact Dawn Wiggins, RCVS Council Secretary, on d.wiggins@rcvs.org.uk.
In a 2019 BVA Voice of the Veterinary Profession Survey, 89% of vets said that they would like to play a more active role in the UK sustainability agenda.
The new checklist includes four major areas for action that cover practising responsible resource use, being sustainable in your operation, using medicines responsibly, and sustaining the team. Each theme has a list of ways that these actions can be achieved.
Vet Sustain founder and director, Laura Higham said: "Veterinary professionals and members of the vet-led team are extremely well positioned to show leadership in sustainability, in their workplaces and in their communities.
"Our new checklist helps veterinary teams to put their sustainability intentions in to practice, through a number of practical steps that will ultimately support the wellbeing of our patients, ourselves and the natural world."
BVA Junior Vice President, Justine Shotton said: "We know that lots of our members are passionate about the environment, and the ‘Greener Veterinary Practice Checklist’ is a great place to start for any veterinary team wanting to work in a more environmentally friendly way.
Jo Oakden RVN BVNA President said: "Environmental Sustainability is really important to us at the BVNA; we are currently going through the process of Environmental Accreditation. Veterinary Nurses are ideally placed to get involved and drive eco-friendly changes within the veterinary practice."
For more information, visit: https://vetsustain.org/
However, the attainment of clinical remission did reduce the likelihood of subsequent death due to gastrointestinal disease.
In the study titled “Outcome of chronic inflammatory enteropathy in cats: 65 cases (2011-2021)”1, cats diagnosed with chronic inflammatory enteropathy were retrospectively identified from three medical records databases, and follow-up information obtained from the referring veterinary surgeon.
This information was used to determine if clinicopathological variables were associated with death due to gastrointestinal disease in diagnosed cats.
Sixty-five cats with chronic inflammatory enteropathy were included in the study, with follow-up information available for 54 cats (83%).
Of these, 37% (n=20) were euthanised due to gastrointestinal disease and 46% (n=25) were alive and in clinical remission, with 64% (n=16) of these diagnosed with food-responsive enteropathy.
The study did not find a correlation between the tested clinicopathological variables, measured at the time of histopathological diagnosis, and death due to gastrointestinal disease, or length of survival in these cats before death due to gastrointestinal disease.
This, the authors say, suggests that alternative diagnostic measures should be identified to definitively investigate outcome and survival in cats with chronic inflammatory enteropathy.
The study also adds weight to previous research which recommends the use of therapeutic diets in cats with chronic inflammatory enteropathy, although further research is needed to clarify a favourable treatment protocol.
First author, Dr Yuvani Bandara, said: “Knowledge that the attainment of clinical remission reduces the likelihood of subsequent death due to feline chronic inflammatory enteropathy is important for veterinary surgeons and owners.
"We hope that our findings can act as a foundation for further research to investigate factors that support the attainment of clinical remission in affected cats.
"Thank you to BSAVA PetSavers for funding this study.”